JJ
LAB icon

Johnson & Johnson’s Standard BioTools LAB Stock Holding History

Johnson & Johnson’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$257K Hold
311,967
– – 0.03% 14
2026
Q1 		$287K Hold
311,967
– – 0.04% 14
2025
Q4 		$399K Hold
311,967
– – 0.07% 16
2025
Q3 		$406K Hold
311,967
– – 0.08% 17
2025
Q2 		$371K Hold
311,967
– – 0.11% 16
2025
Q1 		$337K Hold
311,967
– – 0.1% 17
2024
Q4 		$546K Hold
311,967
– – 0.14% 16
2024
Q3 		$602K Hold
311,967
– – 0.14% 16
2024
Q2 		$552K Hold
311,967
– – 0.14% 18
2024
Q1 		$845K Buy
+311,967
New +$753K 0.02% 19

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Johnson & Johnson's LAB Position: Q2 2026 in Review

Johnson & Johnson held its Standard BioTools (LAB) position steady in Q2 2026 at 311,967 shares worth $257K. The position accounts for 0.03% of the portfolio, ranked #14.

Johnson & Johnson first reported a position in LAB in Q1 2024 and has held it in 10 quarters since. The position peaked at $845K in Q1 2024. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Johnson & Johnson held 311,967 shares of Standard BioTools worth $257K as of Q2 2026.
  • Johnson & Johnson left its Standard BioTools share count unchanged in Q2 2026.
  • Standard BioTools made up 0.03% of Johnson & Johnson's portfolio in Q2 2026, its #14 holding.
  • Johnson & Johnson first reported a position in Standard BioTools in Q1 2024 and has held it in 10 quarters since.
  • Johnson & Johnson's Standard BioTools position peaked at $845K in Q1 2024.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Johnson & Johnson's 13F filing for Q2 2026, filed 6 Aug 2026.